» Authors » Udo Abah

Udo Abah

Explore the profile of Udo Abah including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 163
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Taylor M, Martin G, Abah U, Shackcloth M, Granato F, Booton R, et al.
Clin Lung Cancer . 2024 Nov; 26(1):e73-e80. PMID: 39489628
Background: The RESECT-90 model was developed to predict 90-day mortality for patients undergoing lung resection but hasn't been externally validated. The aim of this study was to validate the RESECT-90...
2.
Taylor M, Evison M, Michael S, Obale E, Fritsch N, Abah U, et al.
Clin Lung Cancer . 2024 May; 25(5):460-467.e7. PMID: 38796323
Background: Measures of systemic inflammation (MSIs) have been developed and shown to help predict prognosis in patients with lung cancer. However, studies investigating the impact of MSIs on outcomes solely...
3.
Ahmed-Issap A, Mantio K, Jain S, Habib A, Brazier A, Raseta M, et al.
Thorac Cardiovasc Surg . 2023 Aug; 72(3):227-234. PMID: 37625455
Background:  Surgical resection is the gold standard treatment for the management of early-stage lung cancer. Several modifiable factors may significantly influence postoperative morbidity and mortality. We examined the outcomes of...
4.
Ahmed-Issap A, Jain S, Habib A, Mantio K, Spence A, Raseta M, et al.
Thorac Cardiovasc Surg . 2023 Apr; 72(5):379-386. PMID: 37055019
Background:  Body mass index (BMI) has been shown to be an independent predictor of survival following lung resection surgery. This study aimed to quantify the short- to midterm impact of...
5.
Garner M, Taylor M, Smith M, Abah U, Shackcloth M, Granato F, et al.
Respir Med . 2022 Nov; 205:107037. PMID: 36347082
Introduction: Pulmonary fibrosis is a risk factor for the development of lung cancer. However, the low incidence of the pathology means that it is not well represented in thoracic surgery...
6.
Brunswicker A, Taylor M, Grant S, Abah U, Smith M, Shackcloth M, et al.
Interact Cardiovasc Thorac Surg . 2021 Dec; 34(6):1054-1061. PMID: 34871415
Objectives: Despite the increased rate of adverse outcomes compared to lobectomy, for selected patients with lung cancer, pneumonectomy is considered the optimal treatment option. The objective of this study was...
7.
Taylor M, Abah U, Hayes T, Eadington T, Smith M, Shackcloth M, et al.
J Cardiothorac Vasc Anesth . 2021 Sep; 36(5):1373-1379. PMID: 34538557
Objectives: Although some evidence to suggest an association between preoperative anemia and reduced overall survival exists, contemporary studies investigating the impact of preoperative anemia on outcomes after resection for primary...
8.
Taylor M, Martin G, Abah U, Sperrin M, Smith M, Bhullar D, et al.
Interact Cardiovasc Thorac Surg . 2021 Jul; 33(6):921-927. PMID: 34324664
Objectives: The ability to accurately estimate the risk of peri-operative mortality after lung resection is important. There are concerns about the performance and validity of existing models developed for this...
9.
Crispi V, Isaac E, Abah U, Shackcloth M, Lopez E, Eadington T, et al.
Postgrad Med J . 2020 Dec; 98(1157):177-182. PMID: 33310899
Purpose Of The Study: Postoperative atrial fibrillation (POAF) is a recognised complication in approximately 10% of major lung resections. In order to best target preoperative treatment, this study aimed at...
10.
Taylor M, Szafron B, Martin G, Abah U, Smith M, Shackcloth M, et al.
Eur J Cardiothorac Surg . 2020 Nov; 59(5):1030-1036. PMID: 33230562
Objectives: National guidelines advocate the use of clinical prediction models to estimate perioperative mortality for patients undergoing lung resection. Several models have been developed that may potentially be useful but...